Gestational trophoblastic neoplasia

John Robert Lurain III

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Testational trophoblastic neoplasia includes invasive mole, choriocarcinoma, and placental site trophoblastic tumor. The overall care rate in the treatment of these tumors currently exceeds 90%. This success is the result of the inherent chemotherapy sensitivity of trophoblastic neoplasms, the effective use of the tumor marker human chorionic gonadotropin (hCG) for diagnosis of disease and monitoring of therapy, the referral of patients to or consultation with specialized treatment centers, the identification of prognostic factors that enhance individualization of therapy, and the development of active combinations of chemotherapy agents used in conjunction with irradiation and surgery to treat patients with the most advanced disease.

Original languageEnglish (US)
Title of host publicationOncology
Subtitle of host publicationAn Evidence-Based Approach
PublisherSpringer New York
Pages899-909
Number of pages11
ISBN (Print)0387242910, 9780387242910
DOIs
StatePublished - Dec 1 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Gestational trophoblastic neoplasia'. Together they form a unique fingerprint.

Cite this